Locations:
Search
BACE1 inhibitor reduces cancer progression in models of glioblastoma
Common cancer therapy increases serious risks in murine models
69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies
Provocative findings from a hypothesis-generating study
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Understudied Src Family Kinase may serve as a potential therapeutic target
Cleveland Clinic’s radiation oncologists select highlights
Dr. Anand-Apte named Chair for Ophthalmology Research
Findings implicate hydrogen sulfide dysfunction, point to potential treatment strategies
Forecasting tool outperforms individual biomarkers
Retired-protein strategy represents new approach to immunization
Advertisement
Advertisement